Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Hemophilia prevalence is nearly three times higher than previously reported

Publish date:: October 10, 2019

Key clinical point: The number of people with hemophilia worldwide is higher than previously estimated, and patients still face a shortened life expectancy.

Major finding: The prevalence of hemophilia A is 17.1 cases per 100,000 males.

Study details: A meta-analysis of registry data from multiple countries concerning male patients with hemophilia A or B.

Disclosures: The study received no financial support. The investigators reported relationships with Pfizer, Roche, Novo Nordisk, and others.

Citation:

Iorio A et al. Ann Intern Med. 2019 Sept 10. doi: 10.7326/M19-1208.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,